Centene (CNC) Competitors

$58.18 -0.09 (-0.16%)

Closing price 03:59 PM Eastern

Extended Trading

$58.35 +0.17 (+0.29%)

As of 08:00 PM Eastern

CNC vs. ELV, MOH, SEM, CI, and HUM

Should you buy Centene stock or one of its competitors? MarketBeat compares Centene with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Cigna Group (CI), and Humana (HUM). These companies are all part of the "medical" sector.

How does Centene compare to Elevance Health?

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Elevance Health presently has a consensus price target of $384.58, indicating a potential downside of 2.23%. Centene has a consensus price target of $53.82, indicating a potential downside of 7.48%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	10 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.57
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32

Elevance Health has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.73
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A

In the previous week, Centene had 1 more articles in the media than Elevance Health. MarketBeat recorded 6 mentions for Centene and 5 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.95 beat Centene's score of 0.70 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 15.58% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Centene	-3.25%	5.57%	1.54%

Summary

Elevance Health beats Centene on 12 of the 17 factors compared between the two stocks.

How does Centene compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Centene (NYSE:CNC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

Molina Healthcare has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$45.43B	0.21	$472M	$3.38	54.72
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A

Molina Healthcare currently has a consensus target price of $174.53, indicating a potential downside of 5.63%. Centene has a consensus target price of $53.82, indicating a potential downside of 7.48%. Given Molina Healthcare's higher possible upside, analysts clearly believe Molina Healthcare is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32

In the previous week, Molina Healthcare had 20 more articles in the media than Centene. MarketBeat recorded 26 mentions for Molina Healthcare and 6 mentions for Centene. Centene's average media sentiment score of 0.70 beat Molina Healthcare's score of 0.43 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Centene	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Molina Healthcare has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Molina Healthcare has a net margin of 0.42% compared to Centene's net margin of -3.25%. Molina Healthcare's return on equity of 8.76% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	0.42%	8.76%	2.32%
Centene	-3.25%	5.57%	1.54%

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Molina Healthcare beats Centene on 11 of the 17 factors compared between the two stocks.

How does Centene compare to Select Medical?

Select Medical (NYSE:SEM) and Centene (NYSE:CNC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

In the previous week, Select Medical had 3 more articles in the media than Centene. MarketBeat recorded 9 mentions for Select Medical and 6 mentions for Centene. Centene's average media sentiment score of 0.70 beat Select Medical's score of -0.21 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Select Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Centene	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.5% of Select Medical shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 16.0% of Select Medical shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Select Medical has a net margin of 2.42% compared to Centene's net margin of -3.25%. Select Medical's return on equity of 6.62% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Select Medical	2.42%	6.62%	2.30%
Centene	-3.25%	5.57%	1.54%

Select Medical has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Select Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Select Medical	$5.45B	0.38	$146.22M	$1.06	15.56
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A

Select Medical presently has a consensus target price of $15.50, indicating a potential downside of 6.03%. Centene has a consensus target price of $53.82, indicating a potential downside of 7.48%. Given Select Medical's higher probable upside, equities analysts plainly believe Select Medical is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Select Medical	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.14
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32

Select Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Centene has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

Summary

Select Medical beats Centene on 10 of the 17 factors compared between the two stocks.

How does Centene compare to Cigna Group?

Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cigna Group has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.28	$5.96B	$23.59	12.13
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A

In the previous week, Cigna Group had 14 more articles in the media than Centene. MarketBeat recorded 20 mentions for Cigna Group and 6 mentions for Centene. Cigna Group's average media sentiment score of 1.09 beat Centene's score of 0.70 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	13 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
Centene	-3.25%	5.57%	1.54%

Cigna Group currently has a consensus price target of $338.35, indicating a potential upside of 18.25%. Centene has a consensus price target of $53.82, indicating a potential downside of 7.48%. Given Cigna Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cigna Group is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.86
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32

Summary

Cigna Group beats Centene on 14 of the 16 factors compared between the two stocks.

How does Centene compare to Humana?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-3.25%	5.57%	1.54%
Humana	0.82%	10.45%	3.75%

Centene has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Humana has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A
Humana	$129.66B	0.28	$1.19B	$9.35	32.68

Centene currently has a consensus price target of $53.82, suggesting a potential downside of 7.48%. Humana has a consensus price target of $249.91, suggesting a potential downside of 18.22%. Given Centene's stronger consensus rating and higher possible upside, equities analysts clearly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32
Humana	3 Sell rating(s)	16 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.15

93.6% of Centene shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.2% of Humana shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Humana had 28 more articles in the media than Centene. MarketBeat recorded 34 mentions for Humana and 6 mentions for Centene. Centene's average media sentiment score of 0.70 beat Humana's score of 0.58 indicating that Centene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	10 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNC vs. The Competition

Export

Metric	Centene	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$28.77B	$50.75B	$6.23B	$22.81B
Dividend Yield	N/A	1.78%	2.80%	4.12%
P/E Ratio	-4.43	22.82	20.66	29.86
Price / Sales	0.15	0.62	546.48	92.36
Price / Cash	12.44	22.16	27.48	18.80
Price / Book	1.43	2.63	9.67	4.59
Net Income	-$6.67B	$1.46B	$3.56B	$1.07B
7 Day Performance	3.25%	1.01%	-1.91%	-1.35%
1 Month Performance	52.67%	14.65%	-2.65%	-1.29%
1 Year Performance	-5.83%	-10.76%	31.17%	21.88%

Centene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNC Centene	2.3892 of 5 stars	$58.18 -0.2%	$53.82 -7.5%	-5.7%	$28.77B	$194.78B	N/A	61,100
ELV Elevance Health	4.2341 of 5 stars	$381.58 +0.9%	$384.58 +0.8%	-2.6%	$82.86B	$200.42B	16.23	97,100
MOH Molina Healthcare	2.0353 of 5 stars	$184.72 -0.7%	$174.53 -5.5%	-43.1%	$9.62B	$45.43B	54.65	19,000	Positive News Insider Trade
SEM Select Medical	3.978 of 5 stars	$16.44 +0.2%	$15.63 -4.9%	+7.5%	$2.04B	$5.45B	15.50	45,300	Analyst Revision
CI Cigna Group	4.9335 of 5 stars	$288.86 +0.3%	$338.35 +17.1%	-11.0%	$76.41B	$278.13B	12.24	67,700	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNC) was last updated on 5/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Competitors

CNC vs. ELV, MOH, SEM, CI, and HUM

How does Centene compare to Elevance Health?

Summary

How does Centene compare to Molina Healthcare?

Summary

How does Centene compare to Select Medical?

Summary

How does Centene compare to Cigna Group?

Summary

How does Centene compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Centene (CNC) Competitors

CNC vs. ELV, MOH, SEM, CI, and HUM

How does Centene compare to Elevance Health?

Do insiders and institutionals believe in ELV or CNC?

Do analysts rate ELV or CNC?

Which has more volatility & risk, ELV or CNC?

Which has better earnings & valuation, ELV or CNC?

Does the media prefer ELV or CNC?

Is ELV or CNC more profitable?

Summary

How does Centene compare to Molina Healthcare?

Which has higher valuation & earnings, MOH or CNC?

Do analysts rate MOH or CNC?

Does the media prefer MOH or CNC?

Which has more volatility and risk, MOH or CNC?

Is MOH or CNC more profitable?

Do insiders & institutionals have more ownership in MOH or CNC?

Summary

How does Centene compare to Select Medical?

Does the media favor SEM or CNC?

Do institutionals and insiders have more ownership in SEM or CNC?

Is SEM or CNC more profitable?

Which has stronger earnings and valuation, SEM or CNC?

Do analysts rate SEM or CNC?

Which has more risk & volatility, SEM or CNC?

Summary

How does Centene compare to Cigna Group?

Do institutionals & insiders have more ownership in CI or CNC?

Which has more volatility & risk, CI or CNC?

Which has better valuation and earnings, CI or CNC?

Does the media favor CI or CNC?

Is CI or CNC more profitable?

Do analysts rate CI or CNC?

Summary

How does Centene compare to Humana?

Is CNC or HUM more profitable?

Which has more risk and volatility, CNC or HUM?

Which has preferable valuation & earnings, CNC or HUM?

Do analysts recommend CNC or HUM?

Do insiders & institutionals have more ownership in CNC or HUM?

Does the media refer more to CNC or HUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools